Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905148-25-000898
Filing Date
2025-03-10
Accepted
2025-03-10 17:41:08
Documents
2
Period of Report
2025-03-06

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1424
2 poa.htm EX-24 5612
  Complete submission text file 0000905148-25-000898.txt   8435
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3005 FIRST AVENUE SEATTLE WA 98121
Business Address
Frohlich Mark W (Reporting) CIK: 0001420482 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-29889 | Film No.: 25725080